MRP ₹934.5
(Inclusive of all Taxes)
₹140.2 Cashback (15%)
Provide Delivery Location
Online payment accepted
Whats That
About Idofnib 100 Capsule
Idofnib 100 Capsule belongs to the category of 'anti-fibrotic medicine', and it is primarily used to treat idiopathic pulmonary fibrosis (IPF) in adults. IPF is an irreversible disease marked by a progressive decline in lung function. The tissues in the lungs become swollen and scarred over time, due to which it gets difficult to breathe deeply. The scarring makes it hard for the lungs to work properly.
Idofnib 100 Capsule contains 'Nintedanib', which helps reduce the scarring and swelling in the lungs by decreasing the release/activity of naturally occurring growth factors in the body, allowing you to breathe better. Idofnib 100 Capsule helps in slowing down the progress of idiopathic pulmonary fibrosis.
Always use this medicine as your doctor has told you or per the package leaflet. You must keep to your doctor's instructions to get the maximum benefit. In some cases, you may experience common side effects such as nausea, tiredness, diarrhoea, indigestion, loss of appetite, headache, and photosensitivity. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
Consult your doctor before taking Idofnib 100 Capsule if you are pregnant or breastfeeding. Idofnib 100 Capsule may cause tiredness and dizziness, so drive with caution. Avoid consuming alcohol with Idofnib 100 Capsule as it could lead to increased dizziness. Idofnib 100 Capsule is not recommended for children below 18 years as safety and effectiveness have not been established. Idofnib 100 Capsule is listed as pregnancy category D. Because Idofnib 100 Capsule can cause harm to the fetus, women of childbearing potential should be advised to avoid becoming pregnant while receiving treatment with Idofnib 100 Capsule . Consult your doctor if you are breastfeeding; your doctor will decide whether the Idofnib 100 Capsule can be taken by breastfeeding mothers or not. Keep your doctor informed about your health condition and medicines to rule out any side effects.
Uses of Idofnib 100 Capsule
Directions for Use
Key Benefits
Idofnib 100 Capsule is an anti-fibrotic medicine used to treat idiopathic pulmonary fibrosis (IPF) in adults. Idofnib 100 Capsule can help effectively slow the rate of lung function decline by 50%. Idofnib 100 Capsule helps reduce the scarring and swelling in the lungs by decreasing the release/activity of naturally occurring growth factors in the body, allowing you to breathe better. Idofnib 100 Capsule helps in slowing down the progress of idiopathic pulmonary fibrosis.
Storage
Drug Warnings
Do not use Idofnib 100 Capsule if you are allergic to any components present in Idofnib 100 Capsule . Idofnib 100 Capsule is listed as pregnancy category D; because Idofnib 100 Capsule can cause harm to the fetus, women of childbearing potential should be advised to avoid becoming pregnant while receiving treatment with Idofnib 100 Capsule . Consult your doctor if you are breastfeeding; your doctor will decide whether the Idofnib 100 Capsule can be taken by breastfeeding mothers or not. Keep your doctor informed about your health condition and medicines to rule out any side effects. Idofnib 100 Capsule may cause tiredness and dizziness, so drive with caution. Avoid consuming alcohol with Idofnib 100 Capsule as it could lead to increased dizziness. Idofnib 100 Capsule is not recommended for children below 18 years as safety and effectiveness have not been established.
Diet & Lifestyle Advise
Side Effects of Idofnib 100 Capsule
Habit Forming
Therapeutic Class
RXCipla Ltd
₹78
(₹2.34 per unit)
RXHetero Drugs Ltd
₹609
(₹54.81 per unit)
RXMacleods Pharmaceuticals Ltd
₹690
(₹62.1 per unit)
We provide you with authentic, trustworthy and relevant information
Drug-Drug Interactions Checker List
Special Advise
Disease/Condition Glossary
Idiopathic pulmonary fibrosis (IPF): Idiopathic pulmonary fibrosis belongs to a group of interstitial lung diseases. It is an irreversible chronic disease marked by a progressive decline in lung function. The tissues in the lungs become inflamed and scarred over time, due to which it gets difficult to breathe properly. The scar tissue, known as fibrosis, becomes thick /stiff over time, making it hard for the lungs to work efficiently. This causes decreased lung function, which leads to increased breathlessness and coughing. Breathing difficulties can lead to other medical problems. Symptoms of IPF are shortness of breath, persistent dry cough, loss of appetite, weight loss, and rounded and widened tips of the fingers and toes.

Have a query?
Alcohol
Safe if prescribed
It is not known if alcohol interacts with Idofnib 100 Capsule . However, as a precautionary measure, you are recommended not to consume alcohol with the Idofnib 100 Capsule to avoid unpleasant side effects.
Pregnancy
Consult your doctor
Idofnib 100 Capsule is listed as pregnancy category D. Because Idofnib 100 Capsule can cause harm to the fetus, women of childbearing potential should be advised to avoid becoming pregnant while receiving treatment with Idofnib 100 Capsule .
Breast Feeding
Consult your doctor
Consult your doctor if you are breastfeeding; your doctor will decide whether Idofnib 100 Capsule can be taken by breastfeeding mothers or not.
Driving
Safe if prescribed
Idofnib 100 Capsule may significantly influence your ability to drive and use machines. You should not drive or operate machinery if you feel sick.
Liver
Consult your doctor
Dose adjustment may be needed. Idofnib 100 Capsule is not recommended for patients with severe hepatic impairment. Please consult your doctor if you have a liver impairment or any concerns.
Kidney
Consult your doctor
Dose adjustment may be needed. Idofnib 100 Capsule is not recommended for patients with an end-stage renal disease requiring dialysis. Please consult your doctor if you have kidney impairment or any concerns.
Children
Safe if prescribed
Idofnib 100 Capsule is not recommended for children below 18 years as safety and effectiveness have not been established.